Table 2.
Compound | Time (h)1 | Volume variation (μL)2,3 | % inhibition4 |
---|---|---|---|
Vehicle control |
1 |
1.53 ± 0.12 |
- |
2 |
1.84 ± 0.17 |
- |
|
3 |
2.22 ± 0.24 |
- |
|
4 |
2.44 ± 0.26 |
- |
|
5 |
2.11 ± 0.21 |
- |
|
Indomethacin |
1 |
1.17 ± 0.01 |
23.53 |
2 |
1.35 ± 0.01 |
26.63 |
|
3 |
1.14 ± 0.02 |
48.6** |
|
4 |
1.03 ± 0.02 |
57.79*** |
|
5 |
0.89 ± 0.01 |
57.82*** |
|
8 |
1 |
1.60 ± 0.15 |
-4.60 |
2 |
1.82 ± 0.16 |
1.10 |
|
3 |
1.68 ± 0.18 |
24.32 |
|
4 |
1.53 ± 0.21 |
37.30** |
|
5 |
1.19 ± 0.18 |
43.60** |
|
9 |
1 |
1.78 ± 0.14 |
-16.34 |
2 |
1.90 ± 0.14 |
-3.26 |
|
3 |
1.96 ± 0.16 |
11.71 |
|
4 |
1.78 ± 0.14 |
27.05 |
|
5 |
1.32 ± 0.07 |
37.44* |
|
11 |
1 |
1.95 ± 0.04 |
-27.45 |
2 |
2.11 ± 0.06 |
-14.67 |
|
3 |
1.82 ± 0.16 |
18.02 |
|
4 |
1.67 ± 0.20 |
31.56* |
|
5 |
1.38 ± 0.22 |
34.60* |
|
12 |
1 |
1.27 ± 0.04 |
16.99 |
2 |
1.44 ± 0.06 |
21.74 |
|
3 |
1.49 ± 0.04 |
32.88* |
|
4 |
1.45 ± 0.07 |
40.57* |
|
5 |
1.22 ± 0.08 |
42.18* |
|
13 |
1 |
1.19 ± 0.16 |
22.22 |
2 |
1.70 ± 0.15 |
7.60 |
|
3 |
1.55 ± 0.12 |
30.2* |
|
4 |
1.66 ± 0.11 |
31.97* |
|
5 |
1.41 ± 0.10 |
33.17* |
|
14 |
1 |
1.39 ± 0.07 |
9.15 |
2 |
1.64 ± 0.10 |
10.87 |
|
3 |
1.90 ± 0.14 |
14.41 |
|
4 |
1.91 ± 0.11 |
21.72 |
|
5 |
1.69 ± 0.12 |
19.90 |
|
15 | 1 |
1.46 ± 0.08 |
4.57 |
2 |
1.78 ± 0.08 |
3.26 |
|
3 |
1.96 ± 0.10 |
11.71 |
|
4 |
2.02 ± 0.26 |
17.21 |
|
5 | 1.98 ± 019 | 6.16 |
1Time after carrageenan injection (0.1 mg/paw), number of animals in each group n = 6.
2All compounds were administered i.p, at the dose of 50 μmol/kg.
3Volume variation is the difference between the volumes of paw pre and post of Carrageenan injection.
4% of inhibition obtained by comparison with vehicle control group, *P < 0.05 , **p < 0.01, ***p < 0.001 significant from control.